David Baskin, MD
Neurological Surgery · Houston, TXNPI 1215962485
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (41.6%), royalties or licence payments and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Surgical Theater. Inc. at 47.8% of the total.
Across 45 payments — averaging $323.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Surgical Theater. Inc.$7K
- Brainlab, Inc.$6K
- Medtronic$730
- Pfizer$190
- Zap Surgical Systems, Inc.$160
- Globus Medical$147
- plus $244 from 6 others
Across 1 payment — averaging $6500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Baxter Healthcare$7K
What the payments were for
- Royalty or licence$6,00041%
- Travel & lodging$6,05842%
- Food & beverage$2,49217%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Surgical Theater. Inc. | 8 | $6,969 |
| Brainlab, Inc. | 5 | $6,133 |
| Medtronic(3 entities) | 14 | $730 |
| Pfizer | 9 | $190 |
| Zap Surgical Systems, Inc. | 1 | $160 |
| Globus Medical | 1 | $147 |
| KARL Storz Endoscopy-america | 1 | $74 |
| GSK | 2 | $57 |
| Stryker | 1 | $38 |
| Omniscient Neurotechnology America Ltd | 1 | $30 |
| Novocure Inc. | 1 | $27 |
| SK Life Science, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,574 in reported general payments places this provider in the 75th percentile of 582 neurological surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 51 | $923 |
| Lacosamide | 11 | $239 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Houston
- Andrew RoeserHouston$660K
- Paul HolmanHouston$516K
- Taylor GistHouston$447K
- Meng HuangHouston$324K
- Laurence RhinesHouston$322K
- Omar TanweerHouston$254K
- Jeremy WangHouston$231K
- Alexander RopperHouston$208K
- Fangyi ZhangHouston$192K
- Ashwin ViswanathanHouston$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.